UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000001495
Receipt number R000001664
Scientific Title Investigation of MDCT Plaque Assessment in patients receiving Cholesterol lowering with Pitavastatin (IMPACT)
Date of disclosure of the study information 2008/11/11
Last modified on 2017/05/31 17:46:26

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

Investigation of MDCT Plaque Assessment in patients receiving Cholesterol lowering with Pitavastatin (IMPACT)

Acronym

IMPACT

Scientific Title

Investigation of MDCT Plaque Assessment in patients receiving Cholesterol lowering with Pitavastatin (IMPACT)

Scientific Title:Acronym

IMPACT

Region

Japan


Condition

Condition

Patients with non-calcified coronary plaque detected with MDCT

Classification by specialty

Cardiology Radiology

Classification by malignancy

Others

Genomic information

NO


Objectives

Narrative objectives1

The effect of chelesterol lowering by pitavastatin on plaque CT value compared with control group

Basic objectives2

Efficacy

Basic objectives -Others


Trial characteristics_1


Trial characteristics_2


Developmental phase



Assessment

Primary outcomes

The comparison of the plaque CT value change between the groups

Key secondary outcomes

a. The relationship between plaque CT value and the cholesterol level.
b.The relationship between plaque CT value and the oxidative stress and inflamation marker.
c. The change of HbH1c between the groups


Base

Study type

Interventional


Study design

Basic design

Parallel

Randomization

Randomized

Randomization unit


Blinding

Open -no one is blinded

Control

Active

Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms

2

Purpose of intervention

Treatment

Type of intervention

Medicine

Interventions/Control_1

pitavastatin 2mg per day orally for 12 months.

Interventions/Control_2

Stopping smoking, life style change and increasing exercise are reccomended. When the decrease in cholesterol level is not satisfactory, plavastatin will be administered.

Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

20 years-old <=

Age-upper limit

90 years-old >

Gender

Male and Female

Key inclusion criteria

1)Patients with coronary non-calcified plaques detected by MDCT
2)Patients with hypercholesterolemia as defined by any of the following criteria: i) TC >220 mg/dl; ii) LDL-C >140 mg/dl; iii) cholesterol-lowering treatment is necessary in accordance with the investigator's judgement when LDL-C >120 mg/dl or TC >200 mg/dl.
3) Patients 20 years or older at the time of their consent.
4) Patients giving written consent by their own volition after being provided sufficient explanation for participation in this clinical trial.

Key exclusion criteria

1)The stenosis at the lesion where the plaque CT value estimation planned is more than 90%(AHA criteria).
2)Patients who have undergone previous PCI on the lesion site where the evaluation of coronary plaque CT value is planned.
3)Patients who might undergo PCI on the lesion where the plaque planned for the estimation of the CT value is located.
4)Patients receiving lipid-lowering drugs (pitavastatin, atorvastatin, rosvastatin).
5)Patients with familial hypercholesterolemia.
6)Patients with cardiogenic shock.
7)Patients receiving cyclosporine.
8)Patients with any allergy to pitavastatin
9)Patients with any allergy to contrast medium
10)Patients with hepatobiliary disorders.
11)Pregnant women, women suspected of being pregnant, or lactating women.
12)Patients with renal disorders or undergoing dialysis.
13)Patients who are ineligible in the opinion of the investigator.

Target sample size

100


Research contact person

Name of lead principal investigator

1st name
Middle name
Last name Tomoko Nao

Organization

Yamaguchi University Graduate School of Medicine

Division name

Cardiology

Zip code


Address

1-1-1 Minami-Kogushi, Ube, Yamaguchi 755-8505, Japan

TEL

0836-22-2248

Email

nao@yamaguchi-u.ac.jp


Public contact

Name of contact person

1st name
Middle name
Last name Tomoko Nao

Organization

Yamaguchi University Graduate School of Medicine

Division name

Cardiology

Zip code


Address

1-1-1 Minami-Kogushi, Ube, Yamaguchi 755-8505, Japan

TEL

0836-22-2248

Homepage URL


Email

nao@yamaguchi-u.ac.jp


Sponsor or person

Institute

Yamaguchi University Graduate School of Medicine,Department of Medicine and Clinical Science

Institute

Department

Personal name



Funding Source

Organization

Yamaguchi University Graduate School of Medicine,Department of Medicine and Clinical Science

Organization

Division

Category of Funding Organization

Self funding

Nationality of Funding Organization



Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization


Address


Tel


Email



Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions



Other administrative information

Date of disclosure of the study information

2008 Year 11 Month 11 Day


Related information

URL releasing protocol


Publication of results

Published


Result

URL related to results and publications


Number of participants that the trial has enrolled


Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Completed

Date of protocol fixation

2008 Year 09 Month 11 Day

Date of IRB


Anticipated trial start date

2008 Year 10 Month 01 Day

Last follow-up date

2011 Year 07 Month 30 Day

Date of closure to data entry

2011 Year 07 Month 30 Day

Date trial data considered complete

2011 Year 07 Month 30 Day

Date analysis concluded

2013 Year 12 Month 01 Day


Other

Other related information



Management information

Registered date

2008 Year 11 Month 10 Day

Last modified on

2017 Year 05 Month 31 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000001664


Research Plan
Registered date File name

Research case data specifications
Registered date File name

Research case data
Registered date File name